TB Research

Efficacy of unani formulation in patient with COPD: A Case series

Amreen Zehra, Abdul Mannan, Mursaleen Naseer, Yasra Farooqui

Journal of Emerging Technologies and Innovative Research · 2019-11

Abstract

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is defined as a disease state characterized by air flow limitation that is not fully reversible. COPD is the third leading cause of death and affect > 10 million persons in United states. COPD is also increasing public heath importance around world. Estimate suggest that COPD will rise from sixth to the third most common cause of death worlds wide. The prevalence of COPD is higher in countries where smoking is highly prevalent. The prevalence range between 2 to 22 percent among the men and 1.2 to 19 percent women in different population based studies across India. The aim of present study is to assess the safety and efficacy of polyherbal unani formulation in the treatment of COPD. METHODS: A case series was conducted on 5 diagnosed cases of COPD attending the Moalejat OPD – 4 at AKTCH, AMU Aligarh. RESULTS AND OBSERVATIONS: All the symptoms like Dyspnoea, cough, sputum production were significantly improved after the 60 days treatment with unani formulation. The result was analyzed and shown on CAT score and spirometry (FEV1,FEV1/FVC). CONCLUSION: The preliminary findings indicate that this unani drug formulation is effective in COPD patients.

MeSH terms

  • COPD
  • Medicine
  • Spirometry
  • Pulmonary disease
  • Cause of death
  • Sputum
  • Population
  • Disease
  • Internal medicine
  • Intensive care medicine